Table 1.

Donors in Cohort

No.	Ancestrya	Panel resultsb	NGSc
1	Latin American	DHCR7:c.964-1G>C (CSY); IDUA:p.Q70* (CSY)	8
2	Latin American	HBA:g.-3.7 (GSG)	8
3	African American		7
4	Latin American		7
5	W. European		7
6	E. European/W. European/S. European	GBA:p.N409S (GSG, CSY)	6
7	W. European/S. European		6
8	W. European		5
9	East Asian		5
10	South Asian	SMN1:g.delExon7 (GSG)	5
11	East Asian	SMN1:g.delExon7 (GSG)	5
12	African American		4
13	European/Native American		4
14	S. European		4
15	African American	HBA:g.-3.7 (GSG)	3
16	W. European		3
17	S. European/E. European/W. European	BLM:p.M1T (GSG)	3
18	W. European/Latin American		3
19	E. European		3
20	Asiand		3
21	W. European	ACADM:p.K333E (CSY, TAM)	2
22	W. European/Native American		2
23	W. European/S. European		2
24	W. European	PYGM:p.R50* (CSY)	2
25	S. European		1
26	W. European/E. European		1
27	Latin American		1

^aSelf-identified.

^bHGVS nomenclature.

^cTotal number of DCV and HLGD variants detected by NGS.

^dSelf-reported ancestry not available. Race/ethnicity taken from GSG report used as indication of ancestry.

CSY, Counsyl; DCV, defined clinical variants; GSG, Good Start Genetics; HLGD, high likelihood of gene dysfunction; NGS, next-generation sequencing; TAM, 23andMe.